Hyperuricemia in Children and Adolescents: Present Knowledge and Future Directions

Overview

Journal J Nutr Metab

Publisher Wiley

Date 2019 Jun 14

PMID 31192008

Citations 41

Authors

Masaru Kubota

Affiliations

Soon will be listed here.

Abstract

Recent evidence suggests that hyperuricemia is an important condition in children and adolescents, particularly in association with noncommunicable diseases. This review aims to summarize our current understanding of this condition in pediatric patients. An analysis of serum uric acid reference values in a healthy population indicates that they increase gradually with age until adolescence, with differences between the sexes arising at about 12 years of age. This information should be taken into consideration when defining hyperuricemia in studies. Gout is extremely rare in children and adolescents, and most patients with gout have an underlying disease. The major causes of hyperuricemia are chronic conditions, including Down syndrome, metabolic or genetic disease, and congenital heart disease, and acute conditions, including gastroenteritis, bronchial asthma (hypoxia), malignant disorders, and drug side effects. The mechanisms underlying the associations between these diseases and hyperuricemia are discussed, together with recent genetic information. Obesity is a major cause of hyperuricemia in otherwise healthy children and adolescents. Obesity is often accompanied by metabolic syndrome; hyperuricemia in obese children and adolescents is associated with the components of metabolic syndrome and noncommunicable diseases, including hypertension, insulin resistance, dyslipidemia, and chronic kidney disease. Finally, strategies for the treatment of hyperuricemia, including lifestyle intervention and drug administration, are presented.

Citing Articles

The relationship between anxiety and cardiometabolic risk factors in adolescents with obesity: propensity scores.

Villasis-Keever M, Zurita-Cruz J, Pichardo-Estrada A, Mazon-Aguirre W Front Endocrinol (Lausanne). 2025; 16:1477006.

PMID: 39980848 PMC: 11839440. DOI: 10.3389/fendo.2025.1477006.

High serum uric acid levels are associated with increased prevalence of gallstones in adult women: a cross-sectional study based on NHANES.

Lv G, Wang D, Huang Y, Shi R, Qin C, Chen X Front Med (Lausanne). 2025; 12:1487974.

PMID: 39897593 PMC: 11782260. DOI: 10.3389/fmed.2025.1487974.

A 6-year-old girl with gout: a case report and another unusual presentation.

Yu S, Liang J, Ren Q Transl Pediatr. 2024; 13(11):2077-2087.

PMID: 39649652 PMC: 11621891. DOI: 10.21037/tp-24-354.

An integrated population pharmacokinetic model of febuxostat in pediatric patients with hyperuricemia including gout and adult population of healthy subjects and patients with renal dysfunction.

Iwama R, Nishida K, Ishii D, Iijima T Pharmacol Res Perspect. 2024; 12(6):e70032.

PMID: 39523739 PMC: 11551477. DOI: 10.1002/prp2.70032.

Multiple gouty tophi in a six-year-old.

Adefokun I, Ano-Edward G, Adesina S, Uduagbamen P, Eyesan S Ghana Med J. 2024; 58(3):245-248.

PMID: 39398089 PMC: 11465722. DOI: 10.4314/gmj.v58i3.10.

References

Morley C, Houston I . Acute renal failure and gout as presenting features of acute lymphoblastic leukaemia. Arch Dis Child. 1976; 51(9):723-5. PMC: 1546250. DOI: 10.1136/adc.51.9.723. View

Pui C, Jeha S, Irwin D, Camitta B . Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial. Leukemia. 2001; 15(10):1505-9. DOI: 10.1038/sj.leu.2402235. View

Fairbanks L, Cameron J, Venkat-Raman G, Rigden S, Rees L, Vant Hoff W . Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. QJM. 2002; 95(9):597-607. DOI: 10.1093/qjmed/95.9.597. View

Hart T, Gorry M, Hart P, Woodard A, Shihabi Z, Sandhu J . Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet. 2002; 39(12):882-92. PMC: 1757206. DOI: 10.1136/jmg.39.12.882. View

Feig D, Johnson R . Hyperuricemia in childhood primary hypertension. Hypertension. 2003; 42(3):247-52. PMC: 1800942. DOI: 10.1161/01.HYP.0000085858.66548.59. View

Fuller R, LUCE M, MERTZ E . Serum uric acid in mongolism. Science. 1962; 137(3533):868-9. DOI: 10.1126/science.137.3533.868. View

Denzer C, Muche R, Mayer H, Heinze E, Debatin K, Wabitsch M . Serum uric acid levels in obese children and adolescents: linkage to testosterone levels and pre-metabolic syndrome. J Pediatr Endocrinol Metab. 2004; 16(9):1225-32. DOI: 10.1515/jpem.2003.16.9.1225. View

Alper Jr A, Chen W, Yau L, Srinivasan S, Berenson G, Hamm L . Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension. 2004; 45(1):34-8. DOI: 10.1161/01.HYP.0000150783.79172.bb. View

Becker M, Kisicki J, Khosravan R, Wu J, Mulford D, Hunt B . Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers. Nucleosides Nucleotides Nucleic Acids. 2004; 23(8-9):1111-6. DOI: 10.1081/NCN-200027372. View

10.

Nyhan W . Inherited hyperuricemic disorders. Contrib Nephrol. 2004; 147:22-34. DOI: 10.1159/000082539. View

11.

Mikuls T, Farrar J, Bilker W, Fernandes S, Schumacher Jr H, Saag K . Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Ann Rheum Dis. 2005; 64(2):267-72. PMC: 1755343. DOI: 10.1136/ard.2004.024091. View

12.

Cameron J, Simmonds H . Hereditary hyperuricemia and renal disease. Semin Nephrol. 2005; 25(1):9-18. DOI: 10.1016/j.semnephrol.2004.09.003. View

13.

Malaga S, Pardo R, Malaga I, Orejas G, Fernandez-Toral J . Renal involvement in Down syndrome. Pediatr Nephrol. 2005; 20(5):614-7. DOI: 10.1007/s00467-005-1825-9. View

14.

Ko Y, Huang M, Wang T, Chang S, Tsai L, Tu H . Prevalence and risk factors associated with dyslipidaemia in children and adolescents among ethnic groups in Taiwan. Public Health. 2005; 119(6):489-97. DOI: 10.1016/j.puhe.2004.08.013. View

15.

Choi H, Ford E . Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007; 120(5):442-7. DOI: 10.1016/j.amjmed.2006.06.040. View

16.

Ford E, Li C, Cook S, Choi H . Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007; 115(19):2526-32. DOI: 10.1161/CIRCULATIONAHA.106.657627. View

17.

Verhulst S, van Hoeck K, Schrauwen N, Haentjens D, Rooman R, Van Gaal L . Sleep-disordered breathing and uric acid in overweight and obese children and adolescents. Chest. 2007; 132(1):76-80. DOI: 10.1378/chest.06-2930. View

18.

Torres R, Prior C, Puig J . Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency. Metabolism. 2007; 56(9):1179-86. DOI: 10.1016/j.metabol.2007.04.013. View

19.

Lee M, Wahlqvist M, Yu H, Pan W . Hyperuricemia and metabolic syndrome in Taiwanese children. Asia Pac J Clin Nutr. 2007; 16 Suppl 2:594-600. View

20.

Zhang W, Bao C, Gu Y, Ye S . Glycogen storage disease manifested as gout and myopathy: three case reports and literature review. Clin Rheumatol. 2007; 27(5):671-4. DOI: 10.1007/s10067-007-0798-4. View